Dimensional Fund Advisors LP Makes New $860,000 Investment in Grail, Inc. (NASDAQ:GRAL)

Dimensional Fund Advisors LP acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 48,152 shares of the company's stock, valued at approximately $860,000. Dimensional Fund Advisors LP owned approximately 0.14% of Grail at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of GRAL. FNY Investment Advisers LLC purchased a new stake in Grail during the 4th quarter valued at about $26,000. B & T Capital Management DBA Alpha Capital Management purchased a new stake in Grail during the 4th quarter valued at about $387,000. Wesbanco Bank Inc. purchased a new stake in Grail during the 4th quarter valued at about $523,000. Exchange Traded Concepts LLC purchased a new stake in Grail during the 4th quarter valued at about $507,000. Finally, Slow Capital Inc. purchased a new stake in Grail during the 4th quarter valued at about $2,379,000.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on GRAL. Canaccord Genuity Group increased their price target on shares of Grail from $32.00 to $43.00 and gave the company a "buy" rating in a research note on Wednesday. Morgan Stanley increased their price target on shares of Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th.

Insider Buying and Selling

In related news, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares of the company's stock, valued at approximately $17,461,797.60. This trade represents a 0.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 94,035 shares of the stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the transaction, the chief executive officer now directly owns 734,627 shares of the company's stock, valued at $24,925,894.11. The trade was a 11.35% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 194,948 shares of company stock valued at $6,583,130. Company insiders own 1.85% of the company's stock.

Grail Stock Up 2.4%

Shares of Grail stock traded up $0.92 during mid-day trading on Friday, hitting $39.91. The stock had a trading volume of 2,065,714 shares, compared to its average volume of 1,257,258. The firm has a 50-day moving average of $30.01 and a two-hundred day moving average of $26.65. Grail, Inc. has a 12-month low of $12.33 and a 12-month high of $63.99. The firm has a market cap of $1.41 billion and a P/E ratio of -0.65.

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. The company had revenue of $31.84 million for the quarter, compared to analysts' expectations of $35.80 million. Sell-side analysts expect that Grail, Inc. will post -15.15 earnings per share for the current year.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.